Roundhill Investments, an ETF provider, is launching a fund focused on companies behind weight loss drugs. They believe there will be advancements in these drugs. Additionally, they've released leveraged and inverse ETFs tracking tech stocks, allowing investors to amplify gains or bet negatively on the group. However, these funds are considered risky and require daily monitoring.
